JPH08151315A - Skin cosmetic - Google Patents

Skin cosmetic

Info

Publication number
JPH08151315A
JPH08151315A JP31590594A JP31590594A JPH08151315A JP H08151315 A JPH08151315 A JP H08151315A JP 31590594 A JP31590594 A JP 31590594A JP 31590594 A JP31590594 A JP 31590594A JP H08151315 A JPH08151315 A JP H08151315A
Authority
JP
Japan
Prior art keywords
skin
effect
improving
cosmetic
kallidinogenase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP31590594A
Other languages
Japanese (ja)
Inventor
Mariko Hara
真理子 原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP31590594A priority Critical patent/JPH08151315A/en
Publication of JPH08151315A publication Critical patent/JPH08151315A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PURPOSE: To obtain a skin cosmetic excellent in aged skin-improving effects such as a rough skin-improving effect, a corneum-improving effect, a blood circulation-stimulating effect, and a skin-beautifying effect by compounding a kind of glucoprotein, kallidinogenase. CONSTITUTION: The skin cosmetic contains kallidinogenase which is a glucoprotein having a mol.wt. of approximately 30000. The kallidinogenase exhibits pharmacological actions such as a telangiectatic action, a blood flow- increasing action and a tissue metabolism-improving action. The skin cosmetic stimulates the blood circulation in the skin to improve the functions of the skin, repairs or improves the original functions of the skin to hold the skin in a healthy state, and especially exhibits the remarkable effects, when applied to aged skin. The kallidinogenase is preferably compounded in an amount of 0.001-5.0wt.% based on the whole amount of the skin cosmetic. The skin cosmetic can be applied to e.g. lotions, milky lotions, creams, or packs.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、老化皮膚改善効果(荒
れ肌改善効果、角質改善効果、血行促進効果、美肌効果
等)の優れた皮膚化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin cosmetic having excellent aged skin improving effects (rough skin improving effect, keratin improving effect, blood circulation promoting effect, beautiful skin effect, etc.).

【0002】[0002]

【従来の技術】老化皮膚とは、乾燥した滑らかさのない
荒れ肌で、角質細胞の剥離現象が認められ、結合組織は
コラ−ゲン/エラスチン比が高く、しわが多い皮膚を言
う。また、老化皮膚は細胞代謝の低下により角質層のタ
−ンオ−バ−が遅く、したがって皮膚に老化防止効果が
付与発現するとタ−ンオ−バ−が速くなると言われ、種
々の皮膚組織賦活成分が研究されている。
Aging skin is dry and non-smooth rough skin in which keratinocyte exfoliation is observed, and the connective tissue has a high collagen / elastin ratio and wrinkles. Also, in aging skin, the turnover of the stratum corneum is slow due to a decrease in cell metabolism, and therefore, it is said that the turnover is accelerated when the antiaging effect is imparted to the skin, and various turnover components of skin tissue are activated. Is being studied.

【0003】また、皮膚老化防止効果を持つ化粧料とし
て、現在までにビンポセチン等を配合した化粧料が提案
されてはいる(特開平5−194179号公報)が、実
用上において皮膚の組織機能を修復または改善し、皮膚
が元来保有する機能を回復して皮膚の老化防止効果に著
効を示す程度に改良された皮膚化粧料を得ることは困難
であった。
As a cosmetic having an effect of preventing skin aging, a cosmetic containing vinpocetine or the like has been proposed up to now (Japanese Patent Laid-Open No. 5-194179), but in practice, it has a function of skin tissue. It has been difficult to obtain a dermocosmetic which is repaired or improved, and the function originally possessed by the skin is restored to improve the antiaging effect of the skin.

【0004】そこで、本発明者は、上記の事情に鑑み鋭
意研究した結果、後記皮膚化粧料が老化皮膚改善効果
(荒れ肌改善効果、角質改善効果、血行促進効果、美肌
効果等)に優れることを確認して本発明を完成するに至
った。
Therefore, as a result of intensive studies in view of the above circumstances, the present inventor has found that the skin cosmetics described below are excellent in the aged skin improving effect (rough skin improving effect, keratin improving effect, blood circulation promoting effect, beautiful skin effect, etc.). After confirmation, the present invention was completed.

【0005】[0005]

【発明が解決しようとする課題】すなわち、本発明の目
的とするところは、皮膚老化防止効果(荒れ肌改善効
果、角質改善効果、血行促進効果、美肌効果等)の優れ
た皮膚化粧料を提供するにある。
That is, the object of the present invention is to provide a skin cosmetic excellent in the effect of preventing skin aging (rough skin improving effect, keratin improving effect, blood circulation promoting effect, beautiful skin effect, etc.). It is in.

【0006】[0006]

【課題を解決するための手段】上述の目的は、カリジノ
ゲナ−ゼを皮膚化粧料に配合することによって達成され
る。
The above-mentioned object is achieved by incorporating calidinogenase into skin cosmetics.

【0007】本発明に用いるカリジノゲナ−ゼは公知の
物質であって、その薬理効果としては末梢血管の拡張な
らびに血流増加作用、および組織代謝の改善作用があ
り、高血圧症等の改善に適用されている。カリジノゲナ
−ゼは分子量約30000の糖タンパクである。
The kalidinogenase used in the present invention is a known substance, and its pharmacological effects include dilation of peripheral blood vessels, blood flow increasing action, and tissue metabolism improving action, and it is applied to the improvement of hypertension and the like. ing. Calizinogenase is a glycoprotein with a molecular weight of about 30,000.

【0008】本発明のカリジノゲナ−ゼを配合してなる
皮膚化粧料は、皮膚の血行を促進して皮膚機能を亢進
し、皮膚が本来備えている機能を修復あるいは改善して
皮膚を健常な状態に保持し、特に老化皮膚に適用する場
合、顕著な効果が認められる。
[0008] A skin cosmetic composition containing the calidinogenase of the present invention promotes blood circulation in the skin to enhance skin function, and restores or improves the function originally possessed by the skin to make the skin healthy. When applied to the skin, especially when applied to aged skin, a remarkable effect is observed.

【0009】前記カリジノゲナ−ゼの配合量は、皮膚化
粧料の総量を基準として0.001〜5.0重量%が好
ましい。
The amount of the above-mentioned kalidinogenase is preferably 0.001 to 5.0% by weight based on the total amount of skin cosmetics.

【0010】本発明の皮膚化粧料は、たとえばロ−ショ
ン類、乳液類、クリ−ム類、パック類等に適用すること
ができる。
The skin cosmetic of the present invention can be applied to lotions, emulsions, creams, packs and the like.

【0011】なお、本発明の皮膚化粧料には上記の他に
色素、香料、防腐剤、界面活性剤、顔料、抗酸化剤等を
本発明の目的を達成する範囲内で適宜配合することがで
きる。
In addition to the above, the skin cosmetic of the present invention may be appropriately blended with a dye, a fragrance, an antiseptic, a surfactant, a pigment, an antioxidant, etc. within a range that achieves the object of the present invention. it can.

【0012】[0012]

【実施例】以下、実施例および比較例に基づいて本発明
を詳説する。
EXAMPLES The present invention will be described in detail below based on examples and comparative examples.

【0013】実施例1〜8、比較例1〜2Examples 1-8, Comparative Examples 1-2

【0014】本発明に用いた試験法は、以下の通りであ
る。
The test method used in the present invention is as follows.

【0015】〔荒れ肌改善効果試験〕下脚部に荒れ肌を
有する中高年被験者10名を対象として4週間連続塗布
効果を調べた。被験者の左側下脚外側試験部位に1日1
回約0.5g の試料を塗布し、試験開始前および終了後
の皮膚の状態を表1の判定基準により判定した。右側下
脚部は試料を塗布せず対照とした。
[Rough Skin Improvement Effect Test] The effect of continuous application for 4 weeks was examined for 10 middle-aged and elderly subjects having rough skin on the lower leg. 1 day per day on the left lower leg outer test site of the subject
About 0.5 g of the sample was applied, and the condition of the skin before and after the start of the test was evaluated according to the criteria shown in Table 1. The lower right leg was not coated with the sample and served as a control.

【0016】[0016]

【表1】 [Table 1]

【0017】試験前後の試験部位と対照部位の判定結果
を比較し、皮膚乾燥度が2段階以上改善された場合(た
とえば+→−、++→±)を有効、1段階改善された場
合をやや有効、変化がなかった場合を無効とした。試験
結果は有効、やや有効となった被験者の人数で示した。
The determination results of the test site before and after the test and the control site are compared, and when the skin dryness is improved by two stages or more (for example, + →-, ++ → ±), the case where it is improved by one stage is slightly effective. Valid, invalid when there was no change. The test results were shown by the number of subjects who were valid or slightly valid.

【0018】〔角質改善(角質細胞の抗剥離性増大)効
果試験〕前述の荒れ肌改善効果試験開始前および終了後
の被験部皮膚にスコッチテ−プ(ニチバンメンデイング
テ−プ)を接着し、これを剥離した時テ−プに付着した
角質細胞の状態を走査型電子顕微鏡によって詳細に調
べ、表2の基準によって皮膚角質細胞抗剥離性を解析
し、角質改善効果を求めた。
[Test for effect of improving keratin (increasing anti-peeling property of keratinocytes)] Scotch tape (Nichiban Mendeing Tape) was adhered to the skin of the test area before and after the start of the above-described test for improving rough skin effect, and this The state of keratinocytes attached to the tape when peeled off was examined in detail by a scanning electron microscope, and the skin keratinocyte anti-peeling property was analyzed according to the criteria in Table 2 to determine the keratin improving effect.

【0019】[0019]

【表2】 [Table 2]

【0020】評価は4週間連続塗布後の試験部位の評価
点と対照部位のそれとの差が2点以上改善された場合を
有効、1点の場合をやや有効、0点の場合を無効とし
た。判定結果は有効、やや有効となった被験者の人数で
示した。
The evaluation was made effective when the difference between the evaluation points of the test site and the control site after continuous application for 4 weeks was improved by 2 points or more, 1 case was slightly effective, and 0 point was not effective. . The judgment results are shown by the number of subjects who were valid and slightly valid.

【0021】〔皮膚血流量試験法〕ニュ−ジ−ランドホ
ワイト系兎家3羽の腹部を刈毛し、18時間絶食させた
後、ペントパルビト−ルのナトリウム塩を35mg/kg の
割合で静脈注射し麻酔処理した。つぎに、プレ−トタイ
プトランスジュ−サ−を腹部の試料塗布部位(試験部
位)上にセロファンテ−プで固定し、交叉熱電堆式皮膚
血流量(シンエイ社製シンコ−ダ−、201型)を用い
て皮膚血流量(μV)を測定した。試料は3×2cmの皮
膚部位に対して0.1g を均一に塗布し、試料塗布前の
血流量(CB )と試料塗布後一定時間後(たとえば0.
5,1.0,2.0時間後)の血流量(Ct)を測定
し、下記の式により血流量増加率(%)を算出した。試
験結果は、3羽の血流量増加率の平均値で示した。 血流量(%)=〔(Ct−CB )/CB 〕×100
[Skin blood flow test method] The abdomen of three New Zealand White rabbits was shaved and fasted for 18 hours, and then pentoparbitol sodium salt was intravenously injected at a rate of 35 mg / kg. Then, anesthesia was performed. Next, a plate type transducer was fixed on the sample application site (test site) on the abdomen with cellophane tape, and the cross thermoelectric skin flow rate (Shinei Co., Ltd., model 201). Was used to measure the skin blood flow (μV). The sample was uniformly applied to a 3 × 2 cm skin site by 0.1 g, and the blood flow rate (CB) before the sample application and a certain time after the sample application (for example, 0.
Blood flow rate (Ct) after 5, 1.0, 2.0 hours) was measured, and the blood flow rate of increase (%) was calculated by the following formula. The test result was shown by the average value of the blood flow rate increase rate of 3 birds. Blood flow (%) = [(Ct-CB) / CB] x 100

【0022】〔官能テスト(美肌効果試験)〕荒れ肌、
小じわ、乾燥肌等を訴える女子被験者(35〜55才)
10名に試料を1日2回(朝・夕)連続4週間塗布して
4週間後の効果を評価した。試験結果は、皮膚の湿潤
性、平滑性、弾力性の各項目に対して、皮膚に潤いが生
じた、皮膚が滑らかになった、皮膚に張りが生じたと回
答した人数で示した。
[Sensory test (Beautiful skin effect test)] Rough skin,
Female subject (35-55 years old) who complains of fine wrinkles, dry skin, etc.
The sample was applied to 10 persons twice a day (morning and evening) for 4 consecutive weeks, and the effect after 4 weeks was evaluated. The test results were expressed by the number of people who answered that the skin was moistened, the skin became smooth, and the skin became taut for each item of skin wettability, smoothness, and elasticity.

【0023】実施例1〜4、比較例1Examples 1 to 4 and Comparative Example 1

【0024】[スキンロ−ション]表3の組成に表4に
記載通りカリジノゲナ−ゼを配合して下記の調製方法に
よって各々のスキンロ−ションを調製した。
[Skin Lotion] Each skin lotion was prepared by blending the composition shown in Table 3 with calidinogenase as shown in Table 4 by the following preparation method.

【0025】[0025]

【表3】 [Table 3]

【0026】(調製法)C成分のカリジノゲナ−ゼはB
成分に配合して、A,B成分を均一に溶解した後、A成
分とB成分を混合攪拌分散し、ついで容器に充填した。
使用時には内容物を均一に振盪分散して使用した。
(Preparation Method) The C component of calidinogenase is B
After being mixed with the components to uniformly dissolve the components A and B, the components A and B were mixed and dispersed by stirring, and then filled in a container.
At the time of use, the content was uniformly dispersed by shaking before use.

【0027】前記諸試験を実施した結果を表4に記載し
た。
The results of carrying out the various tests are shown in Table 4.

【0028】[0028]

【表4】 [Table 4]

【0029】表4に示した通り、実施例1〜4のカリジ
ノゲナ−ゼを配合したスキンロ−ションは、比較例1と
比較して、諸試験において良好な結果が認められた。
As shown in Table 4, the skin lotions containing the calidinogenases of Examples 1 to 4 showed good results in various tests as compared with Comparative Example 1.

【0030】実施例5〜8、比較例2Examples 5 to 8 and Comparative Example 2

【0031】[スキンクリ−ム]表5の組成にて表4に
記載の通りカリジノゲナ−ゼを配合して各々のスキンク
リ−ムを下記の調製方法によって調製した。
[Skin Cream] Each skin cream was prepared by blending the composition shown in Table 5 with calidinogenase as shown in Table 4 by the following preparation method.

【0032】[0032]

【表5】 [Table 5]

【0033】(調製法)C成分のカリジノゲナ−ゼはB
成分に配合して、A、B成分を各々80℃に加熱溶解し
た後、混合して攪拌しつつ、30℃まで冷却して各スキ
ンクリ−ムを調製した。
(Preparation Method) The C component of calidinogenase is B
Each of the skin creams was prepared by blending the ingredients with each other, heating and dissolving each of the components A and B at 80 ° C., mixing and stirring and cooling to 30 ° C.

【0034】前記諸試験を実施した結果を前記表4に示
した。
The results of the above tests are shown in Table 4 above.

【0035】表4に示すごとく、本発明の皮膚化粧料で
ある実施例5〜8のスキンクリ−ムは、それぞれの比較
例と比較して諸特性のすべてに亘って優れていることは
明らかであり、配合特性においても異常は認められなか
った。
As shown in Table 4, it is clear that the skin creams of Examples 5 to 8, which are the skin cosmetics of the present invention, are superior in all of their characteristics as compared with the respective comparative examples. There were no abnormalities in the compounding characteristics.

【0036】[0036]

【発明の効果】以上記載のごとく、本発明は、皮膚老化
防止効果(荒れ肌改善効果、角質改善効果、血行促進効
果、美肌効果等)の優れた皮膚化粧料を提供することが
できる。
Industrial Applicability As described above, the present invention can provide a skin cosmetic excellent in the skin aging prevention effect (rough skin improving effect, keratin improving effect, blood circulation promoting effect, beautiful skin effect, etc.).

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 カリジノゲナ−ゼを配合することを特徴
とする皮膚化粧料。
1. A skin cosmetic comprising a mixture of calidinogenase.
JP31590594A 1994-11-25 1994-11-25 Skin cosmetic Pending JPH08151315A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP31590594A JPH08151315A (en) 1994-11-25 1994-11-25 Skin cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31590594A JPH08151315A (en) 1994-11-25 1994-11-25 Skin cosmetic

Publications (1)

Publication Number Publication Date
JPH08151315A true JPH08151315A (en) 1996-06-11

Family

ID=18071024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP31590594A Pending JPH08151315A (en) 1994-11-25 1994-11-25 Skin cosmetic

Country Status (1)

Country Link
JP (1) JPH08151315A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010143884A (en) * 2008-12-22 2010-07-01 Shiseido Co Ltd Chapped skin improving agent
JP2015151390A (en) * 2014-02-18 2015-08-24 共栄化学工業株式会社 Humectant, antiinflammatory agent, antioxidant, skin turnover improver, cell activator and skin-whitening agent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010143884A (en) * 2008-12-22 2010-07-01 Shiseido Co Ltd Chapped skin improving agent
JP2015151390A (en) * 2014-02-18 2015-08-24 共栄化学工業株式会社 Humectant, antiinflammatory agent, antioxidant, skin turnover improver, cell activator and skin-whitening agent

Similar Documents

Publication Publication Date Title
JPH10130135A (en) Cosmetic for preventing aging of skin
JPH0733637A (en) Skin cosmetic
JPH0146483B2 (en)
JPH08151315A (en) Skin cosmetic
JPH11180851A (en) Skin cosmetic
JP3078051B2 (en) Anti-aging skin cosmetics
JPS627162B2 (en)
JP3532713B2 (en) Skin cosmetics
JP3534941B2 (en) Anti-aging skin cosmetics
JP3121957B2 (en) Anti-aging skin cosmetics
JP2000128742A (en) Cosmetic for hair
JPH0426606A (en) Skin cosmetic
JPH05194179A (en) Skin cosmetic
JP2007269678A (en) Skin irregularity repairing cosmetic
JPH10306010A (en) Skin cosmetic
JPH06256155A (en) Skin aging-preventing cosmetic
JPH06263626A (en) Skin cosmetic
JP2813695B2 (en) Anti-aging agent for skin and skin cosmetic containing the same
JPS6253484B2 (en)
JPS62255405A (en) Skin cosmetic
JP2977683B2 (en) Skin cosmetics
JP3534947B2 (en) External preparation for skin
JPH062661B2 (en) Skin cosmetics
JPH07133219A (en) Skin cosmetic
JPH0692290B2 (en) Skin cosmetics